MedTech Innovator

Robotic Hospital Nutrition Management Systems

Garwood Medical Devices, LLC develops and manufactures medical devices related to infection, perio-prosthetic, and wound healing. It offers BioPrax, a minimally invasive device that targets and eliminates biofilm infections on prosthetic knee implants during early intervention procedures. Garwood Medical Devices, LLC was formerly known as Enermed, LLC and changed its name to Garwood Medical Devices, LLC in December 2015. Garwood Medical Devices, LLC was incorporated in 2014 and is based in Buffalo, New York.

Corveus Medical is focused on creating innovative solutions to prevent heart failure through the development of a neuromodulation device. This catheter-based technology aims to safely and effectively access nerve tissue, enabling nerve ablation for improved treatment outcomes. By employing minimally invasive methods, Corveus Medical seeks to alleviate both the clinical and economic burdens associated with heart failure, marking a significant advancement in the field of cardiac care. The company is committed to delivering consistent results and enhancing patient quality of life through its pioneering approach to heart failure treatment.

LiveMetric is a medical device company developing non-invasive sensing and deep data analytics solutions. The company transforming the care and condition-management of hypertension and cardiovascular diseases. Using their own proprietary, non-invasive arterial pressure technology, they provide a wearable, non-invasive medical device which enables AI-augmented care and condition management treatment services management. LiveMetric delivers high fidelity arterial pressure waveforms and detailed activity mapping of the single user at any time. They seek to empower individuals, payors, self-insured employers and healthcare providers with an accurate, fact-based, personalized care platform that has the potential for improving the care and lives of over 1 Billion people worldwide who suffer from these conditions. The company's goal is to provide prescribed patients, caregivers, and payors with pertinent data and detailed daily activity mapping.

CARI Health is a digital health company based in San Diego, California, that specializes in the development of remote medication monitors. Founded in 2015 and incorporated in 2021, the company creates wireless sensors that patients wear on their skin. These sensors continuously transmit real-time data about medication levels to the cloud, allowing clinicians to safely prescribe, dose, and monitor adherence to critical medications. By providing this innovative solution, CARI Health aims to enhance patient care and improve health outcomes through better medication management.

ConKay Medical Systems is an early-stage medical device company focused on developing innovative solutions to address valvular regurgitation in patients suffering from progressive heart failure. The company's technology is centered around annular repair, which targets the primary cause of functional regurgitation while preserving the integrity of healthy leaflets. This approach aims to enhance the effectiveness of cardiovascular care, providing healthcare professionals with advanced tools to better manage this condition.

Healthcare X.0 is an online healthcare platform that provides its clients with digitization solutions. The platform provides its clients with health, vascular, patient, onco, nephro, cardio, wound, tele, patient, and diabetic assist database solutions. Healthcare X.0 was launched in 2013 by and is based in Niedersachsen.

Augment Health is a medical device company in the southeast United States. Augment Health is focused on improving patient quality of life and care outcomes, initially focused on the population of catheter users with limited bladder sensation. They have developed a bladder management system that lets patients know when they need to go.

SafeBeat Rx replaces a hospitalization with a take-home kit that combines FDA-approved wearables with life-saving ECG software that expands access to proven heart therapies.

52 North Health is focused on enhancing healthcare for cancer patients, specifically those undergoing chemotherapy, by providing a portable and easy-to-use medical device. This device employs artificial intelligence to assess the risk of neutropenic sepsis, a serious and potentially fatal side effect of chemotherapy. Through a finger prick blood test and a corresponding digital platform, the device measures a patient's neutrophil count and C-reactive protein (CRP) levels at home. This functionality allows for timely identification of patients at risk of sepsis, thereby improving their safety and quality of life. By facilitating rapid management of their condition, 52 North Health offers a reliable and cost-effective solution for cancer patients.

CardiaCare is focused on developing a wearable medical device aimed at the non-invasive treatment and monitoring of atrial fibrillation (AFib) in patients. Utilizing a closed-loop approach and machine learning algorithms, the device applies personalized peripheral neuromodulation to elicit a cardiovascular antiarrhythmic response. This innovative technology enables users to effectively reduce the burden of atrial fibrillation and mitigate its precursors, such as premature atrial contractions. As a result, patients can experience rapid clinical and symptomatic relief while managing their condition from the comfort of their homes.

CloudMedx Inc. is a software development company based in Palo Alto, California, that specializes in artificial intelligence solutions for the healthcare sector. Founded in 2014, the company focuses on extracting key clinical concepts from electronic health records to provide actionable insights that enhance clinical operations, documentation, and patient care. Its platform transforms disparate healthcare data into a cohesive view that supports better clinical, treatment, and diagnostic outcomes. By integrating with existing systems, CloudMedx aims to facilitate collaboration among healthcare providers, payers, and patients. The company offers tools for patient engagement, risk stratification, and timely notifications for care needs, serving a diverse clientele that includes managed care organizations, accountable care organizations, and various healthcare facilities. The mission of CloudMedx is driven by a commitment to improve healthcare delivery, stemming from personal experiences related to misdiagnosis and the inefficiencies within the healthcare system.

Actionable, accessible, and affordable feedback system for preventive health maintenance.

Tricog Health Services Pvt Limited, established in 2014 and headquartered in Bengaluru, India, specializes in cloud-connected ECG devices that facilitate the interpretation and analysis of electrocardiography (ECG) reports. The company addresses critical gaps in cardiac care, particularly in regions with limited access to diagnostic tools and trained personnel. Tricog's offerings include the InstaECG and VCardia applications, which enhance the speed and accuracy of cardiac monitoring. The company leverages artificial intelligence to provide real-time reporting and analysis of ECG results, enabling quicker diagnosis of cardiac events. This timely intervention is crucial, as survival rates for heart attack patients significantly improve with prompt treatment, yet many patients experience delays in diagnosis and care. Tricog Health aims to bridge these gaps, potentially saving millions of lives by ensuring that primary care clinics are equipped with affordable and efficient ECG solutions. With a presence in Singapore, Malaysia, and China, Tricog is positioned to expand its impact in the global healthcare landscape.

HD Medical Group Pty Ltd. designs and develops innovative medical products aimed at the screening and detection of cardiac conditions. The company's primary offerings include the ViScope, an electronic stethoscope featuring a visual display for auscultation, and the ViScope MD, which integrates a phonocardiogram visual display along with a murmur indicator. These products are distributed through various channels, enhancing accessibility for healthcare professionals. Founded in 2005 and headquartered in Melbourne, Australia, HD Medical also maintains additional offices in Sunnyvale, California; St. Leonards, Australia; and Chennai, India. The company is recognized as a global leader in the management of cardiovascular disease, focusing on enabling evidence-based patient diagnosis.

Subtle Medical, Inc., a healthcare technology company, develops medical imaging software for clinical imaging centers and hospitals. Its product includes SubtleMR, an artificial intelligence-based image processing software that reduces image noise and increases image sharpness for non-contrast enhanced magnetic resonance imaging (MRI). It enables to reduce cost, imaging time, and radiation/contrast dose. The company was founded in 2017 and is based in Menlo Park, California.

Orbit Genomics applies its proprietary OrbiSeq technology platform to aid in diagnosing and ultimately preventing complex diseases.

Patchd Inc is a healthcare technology company based in San Francisco, California, founded in 2017. The company specializes in developing a wearable device designed to predict sepsis in outpatient settings. Its wireless patch continuously collects vital sign data, enabling healthcare providers to monitor patients effectively. By employing artificial intelligence algorithms, Patchd's technology facilitates the early detection of life-threatening conditions, particularly when used by hospitals for newly admitted patients. This innovative approach aims to enhance patient care and improve outcomes in post-acute care scenarios.

Moving Analytics. is a tele-health company dedicated to helping people thrive after heart disease. Our flagship product is Movn a virtual cardiac rehabilitation program that leverages evidence based guidelines, behavioral science, remote monitoring and personalized coaching to help patients recover to full health after a cardiac event. Movn is currently used by the Veterans Affairs Medical Center, Highmark Health Plan, Kaiser Permanente Northwest and many more health systems across the US.

Respirix, Inc. is a medical technology company based in San Francisco, California, specializing in the development of precise analysis sensors for monitoring breath exhalation and cardiogenic oscillations. Founded in 2015, Respirix focuses on creating hardware and software solutions that provide insights into cardiac health, particularly through non-invasive monitoring of the pulmonary vasculature. Its product pipeline addresses various applications, including at-home monitoring and critical care, specifically targeting conditions such as heart failure and hemodynamics. The company's innovative approach integrates digital health tools to enhance the understanding and management of cardiac conditions.

Koya Medical, Inc. is a company based in Oakland, California, founded in 2018. It focuses on developing a connected wearable platform designed to address the significant unmet needs in the treatment of cancer-related chronic lymphedema and venous diseases. The technology aims to provide a drug-free solution for patients suffering from these conditions, enhancing their quality of life through innovative medical devices.

CloudCath is a company that specializes in developing a remote monitoring platform for peritoneal dialysis patients. Their innovative system utilizes sensor-enabled technology to provide continuous monitoring, allowing for early detection of complications associated with catheter-based treatments. By leveraging Internet of Things (IoT) capabilities, CloudCath's platform enables healthcare providers to remotely oversee patients during their home treatment, significantly reducing the frequency of in-person visits. This approach not only enhances patient safety but also improves the overall management of care for individuals undergoing peritoneal dialysis, ultimately promoting better health outcomes.

AblaCare is a Paris-based company founded in 2017 that focuses on addressing infertility related to Polycystic Ovary Syndrome (PCOS). The company has developed a minimally invasive procedure designed to restore ovulation in patients with PCOS, offering a more natural and less medicalized approach to pregnancy. This innovative treatment is performed transvaginally under ultrasound guidance, eliminating the need for general anesthesia. The procedure can be conducted in a clinic setting, utilizing techniques similar to those used by fertility specialists in in vitro fertilization (IVF). Through its solution, AblaCare aims to enhance the reproductive health and pregnancy experiences of women affected by PCOS.

Conavi Medical is a healthcare company focused on providing image guidance technologies for minimally invasive cardiovascular procedures.

X-COR Therapeutics, based in Allston, Massachusetts, is a medical device company focused on developing innovative CO2 removal devices for patients experiencing acute respiratory failure. Founded in 2017, the company has created a novel consumable hybrid cartridge that enables the removal of excess carbon dioxide from a patient's blood using ultra-low blood flows of less than 300 ml/min. This approach is less invasive and allows for easier placement by nursing staff, making the therapy more accessible and affordable compared to traditional extracorporeal devices, which typically require higher blood flow rates and specialized medical personnel. X-COR's technology is supported by a machine-learning-based control algorithm and is designed to integrate smoothly with existing medical infrastructure, enhancing its usability in clinical settings. The company gained recognition as a runner-up in the 2018 Harvard President’s Innovation Challenge and participated in the MedTech Innovator and MassChallenge cohorts that same year.

Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

Spire, Inc., also known as Spire Health, develops health-tracking devices and remote patient monitoring solutions aimed at managing respiratory chronic diseases. Founded in 2013 and based in San Francisco, the company specializes in continuous respiration sensing and offers ambulatory monitoring services. Its technology includes an activity tracker that monitors physical movement, breathing patterns, and sleep, providing insights into inhalation and exhalation times, apneic events, and daily activities. Spire Health's solutions cater to various health conditions, including chronic obstructive pulmonary disease, congestive heart failure, asthma, sleep disorders, and anxiety. By leveraging advanced algorithms and sensors, Spire Health aims to empower patients and healthcare providers with actionable data to improve health outcomes and overall well-being.

Nebula Industries is solving the problem of medical adhesive related injuries for those with fragile skin, particularly older people, using innovative approaches developed at MIT/Brigham and Women's Hospital.

GreenLight Medical, Inc. is a cloud-based platform that facilitates the procurement process for medical devices within hospitals. Founded in 2014 and headquartered in Nashville, Tennessee, the company offers a software-as-a-service tool designed to enhance the decision-making process regarding medical technology purchases. The platform serves as a collaborative space for hospitals, medical suppliers, and other stakeholders, enabling streamlined workflows and effective project management. By connecting all parties involved, GreenLight Medical promotes cost-effective and quality-conscious purchasing decisions. It manages the entire sales cycle, from the introduction of medical device companies to their approval and use in healthcare facilities, providing actionable data and insights to improve the procurement process.

Aqueduct Critical Care addresses the critical care problem of managing inter-cranial pressure. Its working prototypes demonstrate the ability to allow the patient to move, and minimize attention from nursing staff. Aqueduct Critical Care was founded in 2013 and is based in Bothell, Washington.

Access Vascular, Inc. is a medical technology company based in Bedford, Massachusetts, founded in 2015. The company specializes in developing venous access devices utilizing innovative hydrogel materials to significantly reduce the accumulation of blood components that can lead to thrombosis, infections, and other complications associated with intravenous therapy. Their product line includes peripherally inserted central catheters (PICC), hemodialysis access devices, implantable ports, and drug delivery systems. By addressing common issues in venous access, Access Vascular aims to improve clinical outcomes, decrease healthcare costs, and enhance patient experiences by minimizing morbidity, shortening hospital stays, and reducing pain. The company's initial focus is on launching the HydroPICC, which promises superior performance compared to existing technologies.

Patientory, Inc. is a healthcare technology company based in Atlanta, Georgia, that focuses on personal healthcare solutions. Founded in 2015, Patientory provides a platform that allows patients to manage their medical records and chronic illnesses while enabling healthcare providers to connect with patients effectively. The company's solution utilizes a blockchain-enabled network to gather and analyze healthcare data, offering insights that empower individuals to take charge of their health. By facilitating secure access to and management of health information, Patientory enhances care coordination among doctors, care providers, and patients, ultimately aiming to improve health outcomes and reduce healthcare costs.

Also modify BD: Enspectra Health, Inc. develops a system to image live cellular anatomy. Its system images beneath the skin and displays images in real-time. Enspectra Health, Inc. was formerly known as Zebra Medical Technologies. The company was incorporated in 2012 and is based in Mountain View, California.

AVA Health Technologies is building a disruptive software platform that addresses challenges in pediatric care for children with acute, chronic, and rare conditions Our vision is to fill the gap in funding and focus in dedicated pediatric research and to provide a collaborative ecosystem for care that can facilitate discovery of new cures.

PneuMotion provides continuous respiratory rate monitoring and obstructive apnea detection. PneuMotion seamlessly integrates into a hospital's existing network and allows mobile respiratory monitoring and EHR data collection. Ultra-low cost sensor technology makes this a cost-effective solution for opioid safety.

Avenda Health Inc. is focused on developing a minimally invasive treatment for prostate cancer through its artificial intelligence-based focal laser ablation system. This innovative technology includes a fiber-optic laser and a disposable sensor, which work together with a feedback control system to provide precise treatments. The system integrates prostate images and biopsies using MRI-ultrasound fusion for guidance, allowing procedures to be performed under local anesthesia. Avenda Health aims to deliver safe, effective, and cost-efficient alternatives for patients, enhancing their quality of life while undergoing outpatient treatment. Founded in 2017, the company is headquartered in Santa Monica, California.

PeriCor provides minimally invasive alternatives to infants, children and adults who require interventions including pacemakers, defibrillators or cardiac ablation procedures.

Centerline Biomedical, Inc. is a Cleveland-based company founded in 2014, focused on developing advanced navigation systems for interventional vascular procedures. The company specializes in a non-x-ray based, three-dimensional GPS surgical navigation technology that enhances the precision and outcomes of endovascular procedures while significantly reducing radiation exposure for both patients and healthcare providers. This innovative system assists surgeons in accurately navigating catheters and guide wires through the complex three-dimensional anatomy of patients with vascular diseases, ultimately enabling safer and more effective image-guided surgeries. The technology is rooted in research and development from the Cleveland Clinic, highlighting its commitment to improving surgical practices in the medical field.

Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better. It keeps patients at the forefront by helping vendors and providers integrate securely, easily, and at a reduced cost. It was founded in 2014 and is headquartered in Madison, Wisconsin.

Catalia Health Inc. is a San Francisco-based company that develops a cloud-based patient care management platform aimed at enhancing healthcare delivery. Established in 2014, the company integrates artificial intelligence, psychology, and medicine to improve patient engagement and support. Its platform provides healthcare providers with real-time data on patient progress and challenges, facilitating effective communication through mobile apps, web interfaces, and an interactive robotic coach. By delivering tailored conversations to patients, Catalia Health aims to address ongoing healthcare issues, ultimately enabling healthcare professionals to monitor adherence to treatment and improve overall patient outcomes.

SafeHeal is a medtech company focused on developing innovative medical devices specifically for digestive surgery. Established by MD Start, a medtech accelerator that brings physician inventions to market, SafeHeal has received funding from both MD Start and Sofinnova Partners. The company has been recognized for its contributions to the field, receiving accolades such as the Worldwide Innovation Challenge laureate in 2015 and the Charles Foix grant for its innovations aimed at enhancing the quality of life for elderly individuals. SafeHeal was also acknowledged as the most promising MedTech start-up at the Biovision 2016 investor conference and was a finalist in the global Medtech Innovator competition in 2016.

SilverCloud Health Limited is a provider of online therapeutic solutions aimed at improving mental wellness. The company develops a platform that offers tailored clinical programs addressing various mental health issues, including emotional health. Founded in 2011 and headquartered in Boston, Massachusetts, with additional offices in Dublin, Ireland, and London, United Kingdom, SilverCloud Health delivers evidence-based digital therapies that enhance user engagement and reduce dropout rates compared to traditional online therapeutic products. By serving the healthcare, medical, and pharmaceutical sectors, SilverCloud Health enables individuals to access professional support quickly and affordably, promoting overall mental health and well-being.

Linear Health Sciences is a medical device company creating products for various types of medical tubing based on its proprietary, breakaway safety-valve technology. This platform technology is designed to improve the healthcare experience for patients, caregivers, and healthcare facilities. The company has made substantial progress toward global patent protections and FDA clearance for the Orchid Safety Release Valve. There is a total addressable market of more than $1 billion annually for devices made by the company, which was founded by a physician and two engineers.

Spry Health, Inc. is a digital health solutions company based in Palo Alto, California, established in 2013. It specializes in developing a clinical-grade wearable device and a disease management platform designed to support chronically ill patients. The company's chargeable wristband monitors daily health and fitness activities, providing real-time analytics through a mobile application. This technology enables healthcare organizations to enhance patient outcomes, manage chronic conditions, prevent medical emergencies, and reduce hospitalizations and overall healthcare costs. Spry Health focuses on delivering individualized analytics that assist healthcare payers in efficiently managing the small percentage of patients who contribute significantly to health spending.

Tueo Health specializes in asthma management through the development of an innovative monitoring system aimed at improving control for children with asthma. The company offers a solution that combines accurate, objective indicators of asthma control with valuable clinical insights tailored to the needs of patients and their families. Utilizing a contactless sensor, the application enables users to monitor and manage asthma treatment progress effectively. This approach not only enhances understanding of asthma conditions but also supports families in achieving optimal health outcomes.

V-Sense Medical specializes in the development of remote medical monitoring devices that utilize advanced radar technology to monitor vital signs without direct contact with patients. By eliminating the need for traditional instruments such as wires, electrodes, and blood pressure cuffs, V-Sense Medical addresses significant challenges in medical facilities, including patient safety and comfort, measurement accuracy, and the efficiency of healthcare delivery. Their innovative approach allows for continuous monitoring of critical health metrics like heart rate and respiratory rate, providing healthcare professionals with real-time insights and alerts regarding patient health. This technology not only enhances the precision of medical assessments but also streamlines workflows, ultimately facilitating quicker and more effective patient care in urgent medical environments.

Mindera Health is a biotechnology company specializing in non-invasive molecular testing devices for skin cancer and other skin diseases. Founded in 2013 and based in Palo Alto, California, the company has developed innovative solutions such as a micro-needle array patch that allows for pain-free and targeted extraction of biomarkers, including RNA, DNA, and proteins, without the need for traditional skin biopsies. Mindera Health focuses on scalable technologies that facilitate the collection and evaluation of genetic data, enabling patients, healthcare professionals, and payers to make informed, data-driven decisions regarding treatment options. The company's advancements in biomarker identification and patient prediction analysis leverage deep learning to optimize treatment plans, particularly for conditions like psoriasis, where the technology helps identify patients best suited for specific biologic therapies.

Bloomlife is a women's health company focused on improving maternal health by addressing significant global challenges. It offers a comprehensive remote maternal care platform that combines connected devices with data analytics to enhance access to care and provide personalized feedback to expectant mothers. Central to Bloomlife's solution is a prenatal wearable device that monitors critical health parameters for both maternal and fetal well-being. This technology helps identify modifiable risk factors, detect abnormalities, and predict potential complications, enabling healthcare providers to manage pregnancies more effectively. By promoting early detection and intervention, Bloomlife aims to support families in achieving a healthy start.

Developer of a health information exchange platform designed to create, store, and share advance care planning details. The company's platform offers advanced care technology related to health systems, acute care, and post-acute care facilities along with enhanced care management as well as provides patient education, and documentation, helping patients to make end-of-life care choices, manage their ongoing symptoms, and navigate the complex healthcare system.

Adult Medical Predictive Devices, Diagnostics and Displays, Inc. (AMP3D) has developed a platform for analytics and displays that makes sense of “Big Data” in health care. AMP3D at a glance enables earlier intervention and better outcomes by predicting potentially catastrophic events like emergent intubation, hemorrhage, and severe sepsis that can quadruple mortality and increase lengths-of-stay by more 9 days on average. AMP3D will use demonstrable return-on-investment to sell its platform as a service on a value-based pricing basis, aimed directly at quality measures and performance standards that impact reimbursement and payment. A 20% reduction in emergent intubations at a single medical ICU, for example, can save $600,000 annually; the addressable overall market opportunity for the in-patient market alone is in the billions of dollars.

Swift Health Systems Inc. is a medical device company based in Irvine, California, that specializes in developing innovative orthodontic solutions. The company's flagship product, INBRACE, is an invisible orthodontic system designed to correct malocclusion by being discreetly positioned behind the teeth. INBRACE employs patented self-guiding technology that utilizes light and continuous forces to gently adjust teeth, minimizing discomfort and reducing the frequency of doctor visits. FDA registered, INBRACE aims to make orthodontic treatment more appealing by addressing common patient concerns and facilitating practice growth for clinicians. The system integrates digital treatment planning, computer modeling, and direct digital manufacturing to offer a scalable and personalized approach to a wide range of orthodontic cases, thereby raising the standard of care in the field.

Vixiar Medical, Inc., founded in 2013 and located in Annapolis, Maryland, specializes in developing non-invasive and cost-effective medical devices for monitoring cardiopulmonary diseases. The company's flagship product, Indicor, is a handheld point-of-care device that enables healthcare professionals to monitor worsening heart failure. Vixiar's devices are designed to assess cardiac filling pressure in various settings, including homes, physician's offices, nursing homes, and hospitals. By focusing on improving clinical workflow and delivering economic value, Vixiar aims to address the significant clinical and economic burdens associated with cardiopulmonary conditions.

LifeAssist is a distributor of emergency medical supplies and equipment for first responders, paramedica, and EMS providers.

BrainStem Biometrics is on a mission to reduce risks and extend the lives of elderly critical care patients who many times leave the ICU in worse shape than when they arrived, in part to sedative mis-management. Their firm was established to address the global problem of over-sedation in critical care which costs health systems billions of dollars each year in unnecessary costs and inefficiencies. Furthermore, sub-optimal sedation has been shown to reduce the risks of 180-day mortality for ventilated critically ill patients and has been shown to prolong the duration of ventilation by an estimated 25-40% with associated costs and inefficiencies. They also expect that the mis-management of sedation results in significant increased reliance upon post-ICU healthcare and commensurate cost burdens.

At Hemova Medical, we seek innovative solutions towards vascular access. A patient's access is their lifeline, and currently available options inadequately address the need for a safe, reliable and robust means for hemodialysis administration

Liberate Medical, LLC is a medical device company focused on improving the treatment of patients with chronic obstructive pulmonary disease (COPD) by developing innovative technologies. Founded in 2013 and based in Crestwood, Kentucky, the company has created VentFree, a system that utilizes non-invasive neuromuscular electrical stimulation to contract abdominal wall muscles in sync with a patient’s breathing. This approach aims to minimize disuse atrophy of these muscles, potentially decreasing the duration of mechanical ventilation required for adult patients. By enhancing respiratory muscle function, Liberate Medical seeks to improve patient outcomes and reduce healthcare costs associated with pulmonary disorders.

Yolia Health, based in Mexico City, specializes in developing medical equipment aimed at preserving, restoring, and enhancing vision. The company's flagship product, the True Vision Treatment (TVT), is a non-invasive approach to correcting vision issues such as presbyopia. This innovative treatment allows patients to self-administer a combination of customized contact lenses and specially formulated eye drops in the comfort of their own homes. Remarkably, after just five days of treatment, patients can cease using both the TVT Contacts and Eye Drops, as well as their reading glasses, for up to 12 months before requiring re-treatment. Yolia Health's approach uniquely improves both near and distance vision without compromising either, setting it apart from other alternatives in the market. The company is currently seeking sophisticated investors and key industry partners to further its mission.